These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 9245222)
1. Monitoring warfarin therapy in patients with lupus anticoagulants. Moll S; Ortel TL Ann Intern Med; 1997 Aug; 127(3):177-85. PubMed ID: 9245222 [TBL] [Abstract][Full Text] [Related]
2. Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant. Crowl A; Schullo-Feulner A; Moon JY Ann Pharmacother; 2014 Nov; 48(11):1479-83. PubMed ID: 25104566 [TBL] [Abstract][Full Text] [Related]
3. The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods. Le DT; Weibert RT; Sevilla BK; Donnelly KJ; Rapaport SI Ann Intern Med; 1994 Apr; 120(7):552-8. PubMed ID: 8116992 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant. Thom J; Ivey L; Gilmore G; Eikelboom JW Blood Coagul Fibrinolysis; 2004 Jun; 15(4):353-7. PubMed ID: 15166923 [TBL] [Abstract][Full Text] [Related]
5. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant. Rosborough TK; Shepherd MF Pharmacotherapy; 2004 Jul; 24(7):838-42. PubMed ID: 15303447 [TBL] [Abstract][Full Text] [Related]
6. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem? Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460 [TBL] [Abstract][Full Text] [Related]
7. Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination. Bijsterveld NR; Middeldorp S; Berends F; Büller HR J Thromb Thrombolysis; 2000 Apr; 9(3):263-9. PubMed ID: 10728026 [TBL] [Abstract][Full Text] [Related]
8. Monitoring oral anticoagulant treatment with the TAS near-patient test system: comparison with conventional thromboplastins. Kitchen S; Preston FE J Clin Pathol; 1997 Nov; 50(11):951-6. PubMed ID: 9462248 [TBL] [Abstract][Full Text] [Related]
9. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome. Lawrie AS; Purdy G; Mackie IJ; Machin SJ Br J Haematol; 1997 Sep; 98(4):887-92. PubMed ID: 9326184 [TBL] [Abstract][Full Text] [Related]
10. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study. Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA; Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012 [TBL] [Abstract][Full Text] [Related]
11. Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant. Sanfelippo MJ; Sennet J; McMahon EJ WMJ; 2000 Jun; 99(3):62-4, 43. PubMed ID: 10927985 [TBL] [Abstract][Full Text] [Related]
12. Low frequency of elevated prothrombin times in patients with lupus anticoagulants when using a recombinant thromboplastin reagent: implications for dosing and monitoring of oral anticoagulant therapy. Moore GW; Rangarajan S; Holland LJ; Henley A; Savidge GF Br J Biomed Sci; 2005; 62(1):15-8; quiz 47. PubMed ID: 15816206 [TBL] [Abstract][Full Text] [Related]
13. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206 [TBL] [Abstract][Full Text] [Related]
14. Warfarin monitoring in patients with anticardiolipin antibodies, but without lupus anticoagulants. Mant MJ; Stang L; Etches WS Thromb Res; 2000 Sep; 99(5):477-82. PubMed ID: 10973677 [TBL] [Abstract][Full Text] [Related]
15. During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time. Jonsson PI; Letertre L; Juliusson SJ; Gudmundsdottir BR; Francis CW; Onundarson PT J Thromb Haemost; 2017 Jan; 15(1):131-139. PubMed ID: 27774726 [TBL] [Abstract][Full Text] [Related]
16. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial. Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233 [TBL] [Abstract][Full Text] [Related]
17. Factor X and factor II activity levels do not always agree in warfarin-treated lupus anticoagulant patients. Rosborough TK; Jacobsen JM; Shepherd MF Blood Coagul Fibrinolysis; 2010 Apr; 21(3):242-4. PubMed ID: 20182349 [TBL] [Abstract][Full Text] [Related]
18. Performance of prothrombin-proconvertin time as a monitoring test of oral anticoagulation therapy. Haraldsson HM; Onundarson PT; Einarsdóttir KA; Guõmundsdóttir BR; Pétursson MK; Pálsson K; Kristinsson A Am J Clin Pathol; 1997 Jun; 107(6):672-80. PubMed ID: 9169664 [TBL] [Abstract][Full Text] [Related]
19. Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome. Efthymiou M; Lawrie AS; Mackie I; Arachchillage D; Lane PJ; Machin S; Cohen H Thromb Res; 2015 Jun; 135(6):1191-7. PubMed ID: 25895847 [TBL] [Abstract][Full Text] [Related]